Cargando…

Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke

BACKGROUND: Trimethyllysine, a trimethylamine N‐oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Zhao, Mingming, Wang, Anxin, Xue, Jing, Cheng, Si, Cheng, Aichun, Gao, Jianing, Zhang, Qi, Zhan, Rui, Meng, Xia, Xu, Ming, Li, Hao, Zheng, Lemin, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075360/
https://www.ncbi.nlm.nih.gov/pubmed/34816729
http://dx.doi.org/10.1161/JAHA.121.020979
_version_ 1784701665146830848
author Xu, Jie
Zhao, Mingming
Wang, Anxin
Xue, Jing
Cheng, Si
Cheng, Aichun
Gao, Jianing
Zhang, Qi
Zhan, Rui
Meng, Xia
Xu, Ming
Li, Hao
Zheng, Lemin
Wang, Yongjun
author_facet Xu, Jie
Zhao, Mingming
Wang, Anxin
Xue, Jing
Cheng, Si
Cheng, Aichun
Gao, Jianing
Zhang, Qi
Zhan, Rui
Meng, Xia
Xu, Ming
Li, Hao
Zheng, Lemin
Wang, Yongjun
author_sort Xu, Jie
collection PubMed
description BACKGROUND: Trimethyllysine, a trimethylamine N‐oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship between plasma trimethyllysine levels and stroke outcomes in patients presenting with ischemic stroke or transient ischemic attack. METHODS AND RESULTS: Data of 10 027 patients with ischemic stroke/transient ischemic attack from the CNSR‐III (Third China National Stroke Registry) and 1‐year follow‐up data for stroke outcomes were analyzed. Plasma levels of trimethyllysine were measured with mass spectrometry. The association between trimethyllysine and stroke outcomes was analyzed using Cox regression models. Mediation analysis was performed to examine the mediation effects of risk factors on the associations of trimethyllysine and stroke outcomes. Elevated trimethyllysine levels were associated with increased risk of cardiovascular death (quartile 4 versus quartile 1: adjusted hazard ratio [HR], 1.72; 95% CI, 1.03–2.86) and all‐cause mortality (quartile 4 versus quartile 1: HR, 1.97; 95% CI, 1.40–2.78) in multivariate Cox regression model. However, no associations were found between trimethyllysine and nonfatal stroke recurrence or nonfatal myocardial infarction. Trimethyllysine was associated with cardiovascular death independent of trimethylamine N‐oxide. Both estimated glomerular filtration rate and hs‐CRP (high‐sensitivity C‐reactive protein) had significant mediation effects on the association of trimethyllysine with cardiovascular death, with a mediation effect of 37.8% and 13.4%, respectively. CONCLUSIONS: Elevated trimethyllysine level is associated with cardiovascular death among patients with ischemic stroke/transient ischemic attack. Mediation analyses propose that trimethyllysine contributes to cardiovascular death through inflammation and renal function, suggesting a possible pathomechanistic link.
format Online
Article
Text
id pubmed-9075360
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90753602022-05-10 Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke Xu, Jie Zhao, Mingming Wang, Anxin Xue, Jing Cheng, Si Cheng, Aichun Gao, Jianing Zhang, Qi Zhan, Rui Meng, Xia Xu, Ming Li, Hao Zheng, Lemin Wang, Yongjun J Am Heart Assoc Original Research BACKGROUND: Trimethyllysine, a trimethylamine N‐oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship between plasma trimethyllysine levels and stroke outcomes in patients presenting with ischemic stroke or transient ischemic attack. METHODS AND RESULTS: Data of 10 027 patients with ischemic stroke/transient ischemic attack from the CNSR‐III (Third China National Stroke Registry) and 1‐year follow‐up data for stroke outcomes were analyzed. Plasma levels of trimethyllysine were measured with mass spectrometry. The association between trimethyllysine and stroke outcomes was analyzed using Cox regression models. Mediation analysis was performed to examine the mediation effects of risk factors on the associations of trimethyllysine and stroke outcomes. Elevated trimethyllysine levels were associated with increased risk of cardiovascular death (quartile 4 versus quartile 1: adjusted hazard ratio [HR], 1.72; 95% CI, 1.03–2.86) and all‐cause mortality (quartile 4 versus quartile 1: HR, 1.97; 95% CI, 1.40–2.78) in multivariate Cox regression model. However, no associations were found between trimethyllysine and nonfatal stroke recurrence or nonfatal myocardial infarction. Trimethyllysine was associated with cardiovascular death independent of trimethylamine N‐oxide. Both estimated glomerular filtration rate and hs‐CRP (high‐sensitivity C‐reactive protein) had significant mediation effects on the association of trimethyllysine with cardiovascular death, with a mediation effect of 37.8% and 13.4%, respectively. CONCLUSIONS: Elevated trimethyllysine level is associated with cardiovascular death among patients with ischemic stroke/transient ischemic attack. Mediation analyses propose that trimethyllysine contributes to cardiovascular death through inflammation and renal function, suggesting a possible pathomechanistic link. John Wiley and Sons Inc. 2021-11-24 /pmc/articles/PMC9075360/ /pubmed/34816729 http://dx.doi.org/10.1161/JAHA.121.020979 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Xu, Jie
Zhao, Mingming
Wang, Anxin
Xue, Jing
Cheng, Si
Cheng, Aichun
Gao, Jianing
Zhang, Qi
Zhan, Rui
Meng, Xia
Xu, Ming
Li, Hao
Zheng, Lemin
Wang, Yongjun
Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
title Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
title_full Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
title_fullStr Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
title_full_unstemmed Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
title_short Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
title_sort association between plasma trimethyllysine and prognosis of patients with ischemic stroke
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075360/
https://www.ncbi.nlm.nih.gov/pubmed/34816729
http://dx.doi.org/10.1161/JAHA.121.020979
work_keys_str_mv AT xujie associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT zhaomingming associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT wanganxin associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT xuejing associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT chengsi associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT chengaichun associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT gaojianing associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT zhangqi associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT zhanrui associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT mengxia associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT xuming associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT lihao associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT zhenglemin associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke
AT wangyongjun associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke